Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older

Clinical trial NCT06851832 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06851832
Sponsor: Ab&B Bio-tech Co., Ltd.JS
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Herpes Zoster Herpes Zoster Vaccine

Start date: 2025-02-16
Primary completion: 2026-09-16
Enrollment: 960

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.